1.105
-0.04 (-3.49%)
-0.04 (-3.49%)
Upgrade to Real-Time
Market Closed
| Volume | 1,668,793 |
|
|||||
| News | - | ||||||
| Day High | 1.15 | Low High |
|||||
| Day Low | 1.10 | ||||||
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Canna Trader Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CytoDyn Inc (QB) | CYDY | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.04 | -3.49% | 1.105 | 15:59:54 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.14 | 1.10 | 1.15 | 1.105 | 1.145 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,022 | 1,668,793 | $ 1.1137 | $ 1,858,483 | - | 1.08 - 7.70 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:59:59 | 22 | $ 1.10 | USD |
Period:
Draw Mode:
CytoDyn Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 689.66M | 624.13M | 377.49M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 35.77M | $ - | - | - | - |
CytoDyn (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYDY Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.24 | 1.285 | 1.10 | 1.18 | 1,946,482 | -0.135 | -10.89% |
| 1 Month | 1.18 | 1.45 | 1.08 | 1.21 | 2,225,937 | -0.075 | -6.36% |
| 3 Months | 1.30 | 2.54 | 1.08 | 1.52 | 2,491,793 | -0.195 | -15.0% |
| 6 Months | 2.03 | 2.54 | 1.08 | 1.55 | 2,235,587 | -0.925 | -45.57% |
| 1 Year | 2.47 | 7.70 | 1.08 | 3.20 | 3,466,205 | -1.37 | -55.26% |
| 3 Years | 0.58 | 10.01 | 0.0552 | 3.10 | 3,136,426 | 0.525 | 90.52% |
| 5 Years | 0.75985 | 10.01 | 0.0552 | 2.98 | 1,990,424 | 0.34515 | 45.42% |
CytoDyn (QB) Description
| CytoDyn Inc. is a late-stage biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Leronlimab is in a class of therapeutic monoclonal antibodies designed to address unmet medical needs in the areas of Human Immunodeficiency Virus (HIV), Cancer, and Immunology. |
